| Metric | FY 2022 | Prior Q | FY 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $35.5B | — | — | — | — |
| Op. Income | $6.4B | — | — | — | — |
| Gross Margin | 37.0% | — | — | — | — |
| Net Margin | 14.0% | — | — | — | — |
| EPS (Diluted) | $7.27 | — | — | — | — |
| Free Cash Flow | $4.5B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $35.5B |
| Cost of Revenue | $22.3B |
| GROSS PROFIT | $13.1B |
| R&D Expenses | $1.5B |
| Selling & Marketing | $0 |
| General & Administrative | $5.2B |
| SG&A Expenses | $5.2B |
| Other Expenses | $0 |
| Operating Expenses | $6.7B |
| Cost & Expenses | $29.0B |
| OPERATING INCOME | $6.4B |
| Interest Income | $138M |
| Interest Expense | $414M |
| Other Income/Expenses | -$48M |
| INCOME BEFORE TAX | $6.4B |
| Income Tax Expense | $1.4B |
| Net Income from Continuing Ops | $5.0B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5.0B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5.0B |
| D&A | $1.2B |
| EBIT | $6.8B |
| EBITDA | $8.0B |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| REVENUE | $35.5B |
| Cost of Revenue | $22.3B |
| GROSS PROFIT | $13.1B |
| R&D Expenses | $1.5B |
| Selling & Marketing | $0 |
| General & Administrative | $5.2B |
| SG&A Expenses | $5.2B |
| Other Expenses | $0 |
| Operating Expenses | $6.7B |
| Cost & Expenses | $29.0B |
| OPERATING INCOME | $6.4B |
| Interest Income | $138M |
| Interest Expense | $414M |
| Other Income/Expenses | -$48M |
| INCOME BEFORE TAX | $6.4B |
| Income Tax Expense | $1.4B |
| Net Income from Continuing Ops | $5.0B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $5.0B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $5.0B |
| D&A | $1.2B |
| EBIT | $6.8B |
| EBITDA | $8.0B |
| EPS | $7 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| Net Income | $5.0B |
| Depreciation & Amortization | $1.2B |
| Stock-Based Compensation | $188M |
| Deferred Income Tax | -$180M |
| Other Non-Cash Items | -$160M |
| Change in Working Capital | -$745M |
| OPERATING CASH FLOW | $5.3B |
| Capital Expenditure | -$766M |
| Acquisitions (Net) | -$178M |
| Purchases of Investments | -$1.2B |
| Sales/Maturities of Investments | $1.6B |
| Other Investing Activities | $438M |
| NET CASH FROM INVESTING | -$93M |
| Net Debt Issuance | $317M |
| Common Stock Repurchased | -$4.2B |
| Common Dividends Paid | -$2.7B |
| Other Financing Activities | $272M |
| NET CASH FROM FINANCING | -$6.3B |
| FREE CASH FLOW | $4.5B |
| Net Change in Cash | -$1.3B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $9.6B |
| Short-Term Investments | $483M |
| Net Receivables | $7.4B |
| Inventory | $5.5B |
| Other Current Assets | $1.9B |
| TOTAL CURRENT ASSETS | $25.0B |
| PP&E (Net) | $5.5B |
| Goodwill | $17.5B |
| Intangible Assets | $3.2B |
| Long-Term Investments | $945M |
| Tax Assets | $421M |
| Other Non-Current Assets | $9.7B |
| TOTAL NON-CURRENT ASSETS | $37.3B |
| TOTAL ASSETS | $62.3B |
| Account Payables | $6.3B |
| Short-Term Debt | $4.4B |
| Deferred Revenue | $3.6B |
| Other Current Liabilities | $1.4B |
| TOTAL CURRENT LIABILITIES | $19.9B |
| Long-Term Debt | $15.1B |
| Deferred Revenue NC | $1.3B |
| Deferred Tax Liabilities | $2.1B |
| Other Non-Current Liabilities | $5.7B |
| TOTAL NON-CURRENT LIABILITIES | $25.0B |
| TOTAL LIABILITIES | $44.9B |
| Common Stock | $958M |
| Additional Paid-In Capital | $8.6B |
| Retained Earnings | $45.1B |
| Treasury Stock | -$34.4B |
| Accum. Other Comp. Income | -$3.5B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $16.7B |
| Minority Interest | $629M |
| TOTAL EQUITY | $17.3B |
| TOTAL LIABILITIES & EQUITY | $62.3B |
| Total Debt | $20.5B |
| Net Debt | $10.9B |
